Novonesis (Novozymes) B
(OTC: NVZMY)
|
2:03 PM UTC, 05/23/24 | |||
---|---|---|---|---|
Last: $61.57 | Change: -1.37 | %Change: -2.18% | Volume: 369 |
Open: | $ 61.97 | Volume: | 369 | |
---|---|---|---|---|
High: | $ 61.97 | Yield(%) | 1.51 | |
Low: | $ 61.57 | P/E Ratio (ttm): | 39.92 | |
Dividend ($): | 0.19 | Market Cap ($): | 25.98B | |
EPS ($) | 1.58 | Shares Out: | 410.87M |
% Price Change (last 4 weeks): | 13.73 |
---|---|
% Price Change (last 13 weeks): | 13.20 |
% Price Change (last 26 weeks): | 20.22 |
% Price Change (last 52 weeks): | 23.73 |
% Price Change (year to date): | 14.98 |
Return on Equity (%): | 21.63 |
---|---|
Return on Assets (%): | 10.63 |
Return on Invested Capital (%): | 19.86 |
Gross Profit Margin (%): | 52.03 |
---|---|
Net Profit Margin (%): | 16.89 |
Operating Profit Margin (%): | 24.96 |
50-day Moving Average: | $58.16 |
---|---|
200-day Moving Average: | $51.27 |
Avg. Daily Vol. (last 50 days): | 9,473 |
Avg. Daily Vol. (last 200 days): | 26,220 |
52-wk high: | $63.89 |
52-wk low: | $38.75 |
Bid: | $n/a |
Ask: | $n/a |
Novonesis A/S engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.
|
Novonesis (Novozymes) B
Biologiens Vej 2 Lyngby ND 2800 Phone: n/a Fax: n/a http://www.novonesis.com |
Earnings (1year) ($): | 1.58 |
---|---|
Annual Dividend ($): | 0.57 |
Current P/E Ratio (ttm): | 39.92 |
Book Value ($): | 7.47 |
Cash Flow ($): | 2.86 |
Price/Earnings (x): | 39.92 |
---|---|
Price/Sales (x): | 5.88 |
Price/Book (x): | 7.36 |
Price/Cash Flow (x): | 25.36 |
Quick Ratio (x): | 0.80 |
---|---|
Current Ratio (x): | 1.30 |
LT Debt/Equity (x): | 32.63 |
Total Debt/Equity (x): | 55.67 |